Reports for SITAGLIPTIN

Ingredient

SITAGLIPTIN

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185976
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185973
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-20 178775
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-09 178772
APO-SITAGLIPTIN/METFORMIN XR 500MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2024-02-02 185970
AURO-SITAGLIPTIN 25MG TABLET Resolved 2023-07-24 2023-11-01 199888
AURO-SITAGLIPTIN 25MG TABLET Resolved 2024-04-18 2024-07-17 225605
AURO-SITAGLIPTIN 25MG TABLET Resolved 2024-08-06 2025-01-31 234713
AURO-SITAGLIPTIN 50MG TABLET Resolved 2023-07-24 2023-08-29 199883
AURO-SITAGLIPTIN 50MG TABLET Resolved 2024-01-29 2024-07-17 217667
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
JANUMET 850MG 50MG TABLET To be discontinued 2024-12-12 2024-12-13 245516
STEGLUJAN 5MG 100MG TABLET Discontinued 2021-02-04 2021-02-04 133310
STEGLUJAN 15MG 100MG TABLET Discontinued 2021-02-04 2021-02-04 133307

Showing 1 to 3 of 3